This study focuses on patients with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia and improvement with the use of advanced diabetes technologies; the heterogeneity in the risk of chronic complications, and minimize the psychosocial impact of T1D. We seek to determine patient-specific systemic metabolomic profiles that minimize the risk of hypoglycemia, identify mechanism-based predictive markers and therapeutic targets for diabetes complications, and describe the relationship between metabolic profiles, psychosocial states and cognitive function.
This study focuses on patients with type 1 diabetes (T1D) and seeks to comprehensively study and understand several aspects of T1D including: susceptibility to hypoglycemia and improvement with the use of advanced diabetes technologies; the heterogeneity in the risk of chronic complications, and minimize the psychosocial impact of T1D.